Heartsciences INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Investor Ephraim Fields has filed a Schedule 13G reporting an 8.1% beneficial ownership stake in HeartSciences Inc.